News|Articles|September 3, 2025

Urology Times Journal

  • Vol 53 No 09
  • Volume 53
  • Issue 09

Top 5 benign urology headlines you missed in August 2025

Fact checked by: Hannah Clarke

We recap notable headlines from last month in the benign urology space.

The month of August contained a plethora of noteworthy research and expert perspective across benign conditions in urology. This included an exclusive case report of a single-stage transvaginal repair of erosion of ring pessary with bladder rupture and complete eversion, a report on vaginal estrogen tablets and recurrent ischemic stroke, a recap of studies comparing surgical procedures for pediatric kidney stones, and more.

Related to this article

Rethinking Testosterone Therapy After the FDA Label Revisions
Expert urologists examine how TRAVERSE data and an FDA expert panel prompted proposed label revisions for testosterone therapy as well as what narrowed cardiovascular, prostate, and age-related restrictions mean for evaluating and treating testosterone deficiency.